Systolic hypertension in the elderly: Addressing an unmet need

被引:52
作者
Duprez, Daniel A. [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc,VCRC, Minneapolis, MN 55455 USA
关键词
angiotensin II; arterial stiffness; elderly; renin; systolic hypertension; vascular remodeling;
D O I
10.1016/j.amjmed.2007.10.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systolic hypertension is a major public health issue in the elderly and is often under-recognized and under-treated. The concept that systolic blood pressure increases with age should be considered a pathophysiologic concept. Aging of the cardiovascular system is accompanied by endothelial dysfunction, activation of the renin-angiotensin system and, consequently, vascular remodeling. This process leads to an increase in large artery stiffness and an increase in arterial wave reflections to the heart. These processes in daily clinical practice translate to an increase in systolic blood pressure, which is associated with increased cardiovascular morbidity and mortality. Evidence-based medicine recommendations to treat systolic hypertension in the elderly are based on landmark and recent clinical trials, which clearly demonstrated that treatment of isolated systolic hypertension is associated with significant decreases in cardiovascular morbidity and mortality. However, treatment of systolic hypertension in older adults remains disappointing because therapeutic goals often are not reached. Therefore, emphasis should be placed on the treatment of systolic hypertension in the elderly, and there is need for more effective, individualized antihypertensive therapy. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:179 / U25
页数:9
相关论文
共 32 条
  • [11] Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives - Analysis based on National Health and Nutrition Examination Survey (NHANES) III
    Franklin, SS
    Jacobs, MJ
    Wong, ND
    L'Italien, GJ
    Lapuerta, P
    [J]. HYPERTENSION, 2001, 37 (03) : 869 - 874
  • [12] Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
    Hajjar, I
    Kotchen, TA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 199 - 206
  • [13] Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data
    Jafar, TH
    Schmid, CH
    Landa, M
    Giatras, I
    Toto, R
    Remuzzi, G
    Maschio, G
    Brenner, BM
    Kamper, A
    Zucchelli, P
    Becker, G
    Himmelmann, A
    Bannister, K
    Landais, P
    Shahinfar, S
    de Jong, PE
    de Zeeuw, D
    Lau, J
    Levey, AS
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) : 73 - 87
  • [14] Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy -: A Losartan Intervention For Endpoint Reduction (LIFE) substudy
    Kjeldsen, SE
    Dahlöf, B
    Devereux, RB
    Julius, S
    Aurup, P
    Edelman, J
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Snapinn, S
    Wedel, H
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (12): : 1491 - 1498
  • [15] Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
    Kostis, JB
    Wilson, AC
    Freudenberger, RS
    Cosgrove, NM
    Pressel, SL
    Davis, BR
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) : 29 - 35
  • [16] Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
  • [17] The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial
    Lithell, H
    Hansson, L
    Skoog, I
    Elmfeldt, D
    Hofman, A
    Olofsson, B
    Trenkwalder, P
    Zanchetti, A
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (05) : 875 - 886
  • [18] Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
    Liu, LS
    Wang, JG
    Gong, LS
    Liu, GZ
    Staessen, JA
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 (12) : 1823 - 1829
  • [19] Indapamide SR versus candesartan and amlodipine in hypertension: The X-CELLENT study
    London, G
    Schmieder, R
    Calvo, C
    Asmar, R
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (01) : 113 - 121
  • [20] A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients:: TheVal-Syst study
    Malacco, E
    Varì, N
    Capuano, V
    Spagnuolo, V
    Borgnino, C
    Palatini, P
    [J]. CLINICAL THERAPEUTICS, 2003, 25 (11) : 2765 - 2780